The Hackett Group (HCKT) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Q2 2024 total revenues reached $77.7 million, with revenues before reimbursements at $75.9 million, exceeding guidance and up from $75.6 million year-over-year.
Adjusted EPS was $0.39, at the top end of guidance; GAAP diluted EPS was $0.31, slightly down from $0.32 in Q2 2023.
Net income for Q2 2024 was $8.7 million, nearly flat year-over-year.
Significant momentum in Gen AI consulting, with hundreds of client meetings and the launch of AI XPLR version two, enhancing simulation and enterprise use case capabilities.
Strategic focus on integrating Gen AI across offerings and expanding recurring, high-margin IP-related services.
Financial highlights
Adjusted EBITDA was $16.3 million, or 21.5% of revenues before reimbursements.
Operating income for Q2 2024 was $12.5 million, slightly down from $12.8 million in Q2 2023.
Cash balance at quarter end was $19.1 million; net cash from operating activities was $13.7 million.
Interest expense declined to $0.5 million in Q2 2024 from $0.9 million in Q2 2023.
Share repurchase program authorization remaining: $12.9 million.
Outlook and guidance
Q3 2024 revenues before reimbursements expected between $74.5 million and $76 million.
Adjusted diluted EPS guidance for Q3 is $0.39–$0.41, assuming a 27.7% GAAP tax rate.
Adjusted gross margin expected at 43%-44%; adjusted EBITDA margin at 22%-23%.
Dividend of $0.11 per share declared for Q3 2024, payable October 4, 2024.
Management expects available funds and cash flows from operations to be sufficient for at least the next twelve months.
Latest events from The Hackett Group
- Q4 revenue and adjusted EPS beat guidance as SAP and GenAI drive growth; dividend raised 9%.HCKT
Q4 20248 Jul 2026 - Revenue fell 11–12% but net income rose on cost controls and AI strategy execution.HCKT
Q1 20266 May 2026 - Annual meeting to vote on director, stock plan amendment, compensation, and auditor ratification.HCKT
Proxy filing20 Mar 2026 - Proxy covers director election, compensation, stock plan amendment, and auditor ratification.HCKT
Proxy filing20 Mar 2026 - Q4 2025 beat guidance with SAP and GenAI gains, but margins and EBITDA declined year-over-year.HCKT
Q4 202517 Feb 2026 - Q3 revenue and adjusted EPS beat guidance; GenAI growth accelerated by LeewayHertz acquisition.HCKT
Q3 202417 Jan 2026 - Shareholders will vote on director elections, stock plan expansion, executive pay, and auditor ratification.HCKT
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, stock plan amendment, compensation, and auditor.HCKT
Proxy Filing2 Dec 2025 - Q2 revenue up 1.6% to $78.9M; Gen AI drives growth, but costs weigh on net income.HCKT
Q2 202523 Nov 2025